Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Other liabilities | 590 | 34 |
| Net cash used in operating activities | (10,526) | (52,808) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (4,246) | (7,264) |
| Net cash used in investing activities | (4,246) | (7,264) |
| Cash flows from financing activities: | ||
| Payments of withholding taxes in connection with RSUs vesting | (3,051) | (1,796) |
| Proceeds from the exercise of stock options | — | 25 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is Organogenesis Holdings Inc.'s capex?
- Organogenesis Holdings Inc. (ORGO) reported capex of $1.1M in Q2 2026.
- How has Organogenesis Holdings Inc.'s capex changed year-over-year?
- Organogenesis Holdings Inc.'s capex decreased by 69.8% year-over-year, from $3.64M to $1.1M.
- What is the long-term trend for Organogenesis Holdings Inc.'s capex?
- Over 4 years (2021 to 2025), Organogenesis Holdings Inc.'s capex has grown at a -17.9% compound annual growth rate (CAGR), from $31.22M to $14.15M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Organogenesis Holdings Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude